Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIRx Med

Date Submitted: Dec 14, 2020
Open Peer Review Period: Dec 14, 2020 - Feb 8, 2021
Date Accepted: Mar 8, 2021
Date Submitted to PubMed: Aug 4, 2023
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

The Psychological Impact of Hypertension During COVID-19 Restrictions: Retrospective Case-Control Study

Bonner C, Cvejic E, Ayre J, Isautier J, Semsarian C, Nickel B, Batcup C, Pickles K, Dodd R, Cornell S, Copp T, McCaffery KJ

The Psychological Impact of Hypertension During COVID-19 Restrictions: Retrospective Case-Control Study

JMIRx Med 2021;2(1):e25610

DOI: 10.2196/25610

PMID: 34076628

PMCID: 8078439

The Psychological Impact of Hypertension During COVID-19 Restrictions: Retrospective Case Control Study

  • Carissa Bonner; 
  • Erin Cvejic; 
  • Julie Ayre; 
  • Jennifer Isautier; 
  • Christopher Semsarian; 
  • Brooke Nickel; 
  • Carys Batcup; 
  • Kristen Pickles; 
  • Rachael Dodd; 
  • Samuel Cornell; 
  • Tessa Copp; 
  • Kirsten J McCaffery

ABSTRACT

Background:

It is unclear how people with hypertension are responding to the COVID-19 pandemic given their increased risk, and whether targeted public health strategies are needed.

Objective:

This study aimed to explore differences in psychological and behavioural responses to COVID-19 restrictions between people with and without hypertension in the community.

Methods:

Design: This retrospective case-control study compared people with hypertension to matched healthy controls during COVID-19 lockdown, to determine whether they have higher risk perceptions, anxiety and prevention intentions. Baseline data from a national survey were collected in April 2020 during COVID-19 lockdown. Of 4362 baseline participants, 466 people reported hypertension with no other chronic conditions, and were randomly matched to healthy controls with similar age, gender, education and health literacy. A subset (n=1369) was followed-up at 2 months after restrictions eased, including 147 participants with hypertension only. Risk perceptions, prevention intentions and anxiety were measured.

Results:

At baseline, perceived seriousness was high for both hypertension and control groups. The hypertension group had higher anxiety than controls; and were more willing to have the influenza vaccine. At follow-up, these differences were no longer present in the longitudinal sub-sample. Perceived seriousness and anxiety had decreased, but vaccine intentions for both influenza and COVID-19 remained high (>80%).

Conclusions:

Anxiety was above normal levels during the COVID-19 lockdown. This was higher in the hypertension group, who also had higher vaccination intentions. Locations with prolonged restrictions may require targeted mental health screening for vulnerable groups. Despite a decrease in perceived risk and anxiety after 2 months of lockdown restrictions, vaccination intentions for both influenza and COVID-19 remained high, which is encouraging for future prevention of COVID-19. Clinical Trial: N/A


 Citation

Please cite as:

Bonner C, Cvejic E, Ayre J, Isautier J, Semsarian C, Nickel B, Batcup C, Pickles K, Dodd R, Cornell S, Copp T, McCaffery KJ

The Psychological Impact of Hypertension During COVID-19 Restrictions: Retrospective Case-Control Study

JMIRx Med 2021;2(1):e25610

DOI: 10.2196/25610

PMID: 34076628

PMCID: 8078439

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.